JW Pharmaceutical Corporation (KRX:001065)
South Korea · Delayed Price · Currency is KRW
28,200
-1,250 (-4.24%)
Feb 26, 2026, 11:00 AM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 719.38B | 748.53B | 684.35B | 606.58B | 547.34B | | | | | |
Pharmaceutical Business Growth | -3.89% | 9.38% | 12.82% | 10.83% | 7.04% | | | | | |
| 719.38B | 748.53B | 684.35B | 606.58B | 547.34B | | | | | |
| -3.89% | 9.38% | 12.82% | 10.83% | 7.04% | | | | | |
Source: S&P Global Market Intelligence.